BioLineRx Ltd. Quarterly Assets in USD from Q4 2016 to Q4 2024

Taxonomy & unit
ifrs-full: USD
Summary
BioLineRx Ltd. quarterly Assets history and growth rate from Q4 2016 to Q4 2024.
  • BioLineRx Ltd. Assets for the quarter ending December 31, 2024 was $38.9M, a 39.1% decline year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $38.9M -$25M -39.1% Dec 31, 2024 20-F 2025-03-31
Q2 2024 $64.6M +$5.66M +9.6% Jun 30, 2024 6-K 2024-08-15
Q4 2023 $63.9M -$12.5M -16.3% Dec 31, 2023 20-F 2025-03-31
Q2 2023 $58.9M -$8.9M -13.1% Jun 30, 2023 6-K 2023-08-30
Q4 2022 $76.4M -$5.01M -6.15% Dec 31, 2022 20-F/A 2024-03-26
Q2 2022 $67.8M -$23.5M -25.7% Jun 30, 2022 6-K 2022-08-16
Q4 2021 $81.4M +$34.1M +72.1% Dec 31, 2021 20-F 2023-03-22
Q2 2021 $91.3M +$38.3M +72.4% Jun 30, 2021 6-K 2021-08-18
Q4 2020 $47.3M -$6.28M -11.7% Dec 31, 2020 20-F 2022-03-16
Q2 2020 $53M -$8.97M -14.5% Jun 30, 2020 6-K 2020-08-06
Q4 2019 $53.6M -$2.67M -4.74% Dec 31, 2019 20-F 2021-02-23
Q2 2019 $62M +$9.75M +18.7% Jun 30, 2019 6-K 2019-08-06
Q4 2018 $56.2M -$4.73M -7.76% Dec 31, 2018 20-F 2020-03-12
Q2 2018 $52.2M Jun 30, 2018 6-K 2018-08-13
Q4 2017 $61M +$22M +56.6% Dec 31, 2017 20-F 2019-03-28
Q4 2016 $38.9M Dec 31, 2016 20-F 2018-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.